Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Winckler

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Cell|April 30, 2013
Punctuated evolution of prostate cancer genomesSylvan C Baca, Davide Prandi, Michael S Lawrence, et al.
Nature|May 25, 2012
Melanoma genome sequencing reveals frequent PREX2 mutationsMichael F Berger, Eran Hodis, Timothy P Heffernan, et al.
Nature Genetics|July 6, 2010
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Barry S Taylor, Shantanu Banerji, et al.
Nature Genetics|May 22, 2012
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerChristopher E Barbieri, Sylvan C Baca, Michael S Lawrence, et al.
JAMA Neurology|May 10, 2016
Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary MosaicismGhayda M Mirzaa, Catarina D Campbell, Nadia Solovieff, et al.
Plos Genetics|August 10, 2012
The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traitsBenjamin F Voight, Hyun Min Kang, Jun Ding, et al.
Nature Communications|January 16, 2019
Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular featuresJason J Pitt, Markus Riester, Yonglan Zheng, et al.
Nature|March 25, 2011
Initial genome sequencing and analysis of multiple myelomaMichael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.
Nature Genetics|February 13, 2007
High-throughput oncogene mutation profiling in human cancerRoman K Thomas, Alissa C Baker, Ralph M Debiasi, et al.
Nature Communications|October 18, 2018
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular featuresJason J Pitt, Markus Riester, Yonglan Zheng, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Cell|April 30, 2013
Punctuated evolution of prostate cancer genomesSylvan C Baca, Davide Prandi, Michael S Lawrence, et al.
Nature|May 25, 2012
Melanoma genome sequencing reveals frequent PREX2 mutationsMichael F Berger, Eran Hodis, Timothy P Heffernan, et al.
Nature Genetics|July 6, 2010
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Barry S Taylor, Shantanu Banerji, et al.
Nature Genetics|May 22, 2012
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerChristopher E Barbieri, Sylvan C Baca, Michael S Lawrence, et al.
JAMA Neurology|May 10, 2016
Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary MosaicismGhayda M Mirzaa, Catarina D Campbell, Nadia Solovieff, et al.
Plos Genetics|August 10, 2012
The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traitsBenjamin F Voight, Hyun Min Kang, Jun Ding, et al.
Nature Communications|January 16, 2019
Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular featuresJason J Pitt, Markus Riester, Yonglan Zheng, et al.
Nature|March 25, 2011
Initial genome sequencing and analysis of multiple myelomaMichael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.
Nature Genetics|February 13, 2007
High-throughput oncogene mutation profiling in human cancerRoman K Thomas, Alissa C Baker, Ralph M Debiasi, et al.
Nature Communications|October 18, 2018
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular featuresJason J Pitt, Markus Riester, Yonglan Zheng, et al.
Pageof 5